Pfizer’s $150m Melbourne upgrade to manufacture superbug defence

August 13th, 2024

InnovationAus, Other, 06/08/2024, Joseph Brookes
US biotech giant Pfizer will ramp up manufacturing of antimicrobials and precision medicines from its Melbourne site to combat the rising threat of superbugs after tipping $150 million into production facilities, robotics and artificial intelligence. […] The CSIRO has warned superbugs are “one of the greatest threats facing humanity” and Australia is at the frontline as one of the largest consumers of antibiotics, with the drug’s overuse being the main driver of AMR.

Read more: https://www.innovationaus.com/pfizers-150m-melbourne-upgrade-to-manufacture-superbug-defence/